MedPath

Physical Training in Transposition of the Great Arteries

Not Applicable
Completed
Conditions
Transposition of Great Vessels
Interventions
Behavioral: Training
Registration Number
NCT00837603
Lead Sponsor
Hannover Medical School
Brief Summary

In transposition patients after atrial switch operation, the morphological right ventricle serves as the systemic ventricle. These patients often develop signs of heart failure. It is not known, whether physical training can safely be recommended in these patients- like heart failure guidelines recommend training in patients with normal anatomy. Furthermore it is not known, whether these TGA-patients benefit from training with respect to cardiopulmonary exercise capacity.

Detailed Description

This is a randomized, controlled, prospective trial on the safety of physical training in TGA patients after atrial switch operation.

In transposition patients after atrial switch operation, the morphological right ventricle serves as the systemic ventricle. These patients often develop signs of heart failure. It is not known, whether physical training can safely be recommended in these patients- like heart failure guidelines recommend training in patients with normal anatomy. Furthermore it is not known, whether these TGA-patients benefit from training with respect to cardiopulmonary exercise capacity.

Primary endpoints are Systemic Ventricle Ejection Fraction and Volumes, Exercise Capacity.

Secondary endpoints are Echo Diastolic Function, as well as laboratory markers of heart failure.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • age >=18 years
Exclusion Criteria
  • tricuspid regurgitation grade 2 or more
  • sign. LVOTO or RVOTO
  • pacemaker or defibrillator
  • recent hospitalisation for heart failure (90 days)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TrainingTrainingErgometer Training
Primary Outcome Measures
NameTimeMethod
Cardiac MRI Right Ventricular Ejection Fraction6 and 12 months
Cardiopulmonary exercise capacity6 and 12 months
Secondary Outcome Measures
NameTimeMethod
laboratory markers of heart failure6 and 12 months
Diastolic RV and LV function6 and 12 months
Right ventricular volumes6 and 12 months
Right ventricular mass6 and 12 months
NYHA-class6 and 12 months
quality of life questionnaire6 and 12 months

Trial Locations

Locations (1)

Hannover Medical School

🇩🇪

Hannover, Germany

© Copyright 2025. All Rights Reserved by MedPath